Franková, V, Costa, A, Robert, G, Macek, M, Patch, C, Alexander, E, Arellanesová, A, Clayton-Smith, J, Hunter, A, Havlovicová, M, Pourová, R, Pritchard, M, Roberts, L, Zouboková, V & Metcalfe, A 2022, ' Co-designing models for the communication of genomic results for rare diseases : a comparative study in the Czech Republic and the United Kingdom ', Journal of Community Genetics, vol. 13, no. 3, pp. 313-327 . https://doi.org/10.1007/s12687-022-00589-w Journal of Community Genetics
ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group, Nielsen, H & Thisted, R K 2022, ' Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO) : a randomised controlled trial ', The Lancet. Infectious diseases, vol. 22, no. 5, pp. 622-635 . https://doi.org/10.1016/S1473-3099(21)00751-9 ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group, Johansen, I S & Larsen, L 2022, ' Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO) : a randomised controlled trial ', The Lancet Infectious Diseases, vol. 22, no. 5, pp. 622-635 . https://doi.org/10.1016/S1473-3099(21)00751-9 The Lancet. Infectious Diseases
Phillips, W, Roehrich, J K, Kapletia, D & Alexander, E 2022, ' Global Value Chain Reconfiguration and COVID-19 : Investigating the Case for More Resilient Redistributed Models of Production ', California Management Review, vol. 64, no. 2, pp. 71-96 . https://doi.org/10.1177/00081256211068545